Crown Bioscience Inc.
SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scientific advancement of Patient Derived Xenograft (PDX) technology.
Research Grants up to $50,000 will be awarded to projects focused on accelerating the pace of preclinical innovation and novel PDX methodologies that improve clinical predictions with sound science. The program offers an opportunity for investigators to receive funding for projects that may not receive support through traditional funding channels. Submitted proposals will be reviewed and selected by CrownBio's Scientific Steering Committee with the goal of realizing breakthroughs in preclinical oncology strategies.
"Crown Biosciences recognizes the importance of supporting investigators in early discovery," said Laurie Heilmann, Chief Business Officer at Crown Bioscience. "By investing in the brightest scientific minds, we can evolve the current research paradigms and establish novel tools that will help researchers and drug developers address global health challenges."
For more details on the innovative grant program or to submit a proposal visit: Innovative Grant Program of Oncology Preclinical Early Discovery
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Media Enquiries:
Jody Barbeau
Crown Bioscience Inc. marketing@crownbio.com
WEB:
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Cellebrite DI Ltd14.3.2024 14:01:14 CET | Press release
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
TrueCommerce12.3.2024 13:01:14 CET | Pressemeddelelse
TrueCommerce anerkendes igen som en leder i IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network
NetBet4.3.2024 10:41:43 CET | Press release
NetBet Casino in Denmark Now Features IGT PlayDigital Content
NetBet4.3.2024 10:41:43 CET | Pressemeddelelse
NetBet Casino i Danmark indeholder nu spil fra IGT PlayDigital
FUJIFILM Europe GmbH29.2.2024 12:37:58 CET | Press release
Fujifilm Healthcare Europe partners with R Zero to bring next-gen training simulation technology to European endoscopists
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum